HER2-NEGATIVE

Clinical trials for HER2-NEGATIVE explained in plain language.

Never miss a new study

Get alerted when new HER2-NEGATIVE trials appear

Sign up with your email to follow new studies for HER2-NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New drug combo aims to shrink hard-to-treat stomach cancers

Disease control Not yet recruiting

This study tests a new drug called denikitug, alone or with other treatments, in people with advanced HER2-negative stomach, gastroesophageal junction, or esophageal cancer that has spread or come back after initial therapy. About 120 participants will be randomly assigned to rec…

Matched conditions: HER2-NEGATIVE

Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control

Last updated May 11, 2026 20:52 UTC

HER2-NEGATIVE

Get alerted when new HER2-NEGATIVE trials appear

New drug combo aims to shrink hard-to-treat stomach cancers